Contact Us
Drug Search Results
More Filters [+]

Narrow band uvb phototherapy

Alternative Names: narrow band UVB phototherapy, narrow-band UVB, nbUVB, nb-uvb, narrowband UVB, narrow band UVB, Narrowband Ultraviolet B, Narrow band (310-312 nm) ultraviolet light B
Latest Update: 2025-01-10
Latest Update Note: Clinical Trial Update

Product Description

Astellas Pharma is developing Narrow band uvb phototherapy as a treatment for plaque psoriasis. (Sourced from: https://classic.clinicaltrials.gov/ct2/show/NCT00658606)

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Nondrug

Route of Administration: Topical,Intravenous,Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: United Arab Emirates

Approved Indications: None

Known Adverse Events: None

Company: Astellas Pharma
Company Location: NEW YORK NY 10005
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Narrow band uvb phototherapy

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Type 2 Diabetes|Psoriasis|Vitiligo

Phase 3: Vitiligo

Phase 2: Graft vs Host Disease|Vitiligo|Psoriasis

Phase 1: Dermatitis|Psoriasis|Vitiligo|Mycosis Fungoides

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
DIMC/DUHS/DERMA/001/2024

P4

Not yet recruiting

Vitiligo

2026-12-30

PLIGHT

P1

Recruiting

Mycosis Fungoides

2026-09-01

UPDATE

N/A

Recruiting

Dermatitis, Atopic

2026-06-01

STRAVI

N/A

Recruiting

Vitiligo

2025-10-09

Recent News Events

Date

Type

Title

05/11/2024

PubMed

 Plexin B2 tissue expression and related gene polymorphisms in psoriasis and their relation to NB-UVB and Acitretin therapy.

05/06/2024

News Article

 One Health Direct Increases Efforts And Patient Education for Phototherapy Treatment

05/01/2024

PubMed

 A novel reverse perilesional home phototherapy can promote the repigmentation of vitiligo patches with complete leukotrichia: A 12-week, open-label, double-arm, multicenter, randomized clinical trial.

04/23/2024

PubMed

 Risk of Skin Cancer in Patients with Psoriasis: Single-Center Retrospective Study Comparing Anti-TNFα and Phototherapy.

01/12/2024

News Article

 Phototherapy Equipment Market Size to Surpass US$ 563.38 million by 2031 - Growth Plus Reports

01/09/2024

News Article

 LASEROPTEK Co. Ltd. Partners with The Pinnacle Health Group to Enhance CPT Coding Support for its U.S. Customers Utilizing the U.S. FDA 510(k) Cleared PALLAS & PALLAS Premium UVB Laser Systems

12/19/2023

News Article

 Zerigo Health Appoints Tim Raducha-Grace as Chief Platform Officer

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions